Alvotech

Alvotech

ALVOW

$0.30

Updated: 03/11/2026, 09:21:42

Market Cap
$2.74B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
LU

No historical data available

Company Profile

Alvotech Holdings SA is an Icelandic enterprise that, operating via its subsidiary companies, undertakes the development and fabrication of biosimilar pharmaceuticals destined for international consumption.

USD
NASDAQ
CEO: Lisa Graver
Employees: 1,460
https://www.alvotech.com
Asset Summaries
Latest generated summaries for ALVOW

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for ALVOW.
Share price
$0.30
Market cap
$2.74B
Exchange
NASDAQ
Currency
USD
CEO
Lisa Graver
Employees
1,460
IPO date
16/06/2022
Beta
0.192
Last dividend
$0.00
Day range
$0.30 – $0.30
52-week range
$0.12 – $1.52
1-day performance
21.14%
1-year performance
148.40%
Current drawdown (1Y)
-80.59%
CIK
0001898416
CUSIP
L01800116
ISIN
LU2458333858
Created
07/12/2025, 02:02:54
Last update
03/11/2026, 09:21:42

Track Alvotech with an AI analyst

See which prediction-market events move ALVOW, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to ALVOW from your Railway `news_articles` table.

No news found for this symbol.